Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Experimental & Molecular Medicine|September 30, 2024
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2Yunju Jo, Hye-In Sim, Bohwan Yun, et al.Biomedicines|February 25, 2022
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon CancersDong-Hee Lee, Yu-Jeong Jeong, Ju-Young Won, et al.BMB Reports|June 11, 2025
Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8＋T cell responses in the absence of IL-2Hye-In Sim, Yunju Jo, Hyejin Ahn, et al.BMB Reports|August 29, 2025
Erratum to: Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8＋T cell responses in the absence of IL-2Hye-In Sim, Yunju Jo, Hyejin Ahn, et al.Journal of Experimental & Clinical Cancer Research : CR|October 20, 2023
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicityDong-Hee Lee, Hyejin Ahn, Hye-In Sim, et al.Pageof 1